PSTV
Plus Therapeutics, Inc.Company with tickers: PSTV
CIK
1095981
CUSIP
72941H509
Shares Outstanding
6,883,106
13F Activity (30d)
21 filings
21 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $1,028,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $8,147,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Research & Development | $2,865,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Income | $-7,119,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Net Income | $-6,946,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Basic) | $-1.05 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Diluted) | $-1.05 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |